SEARCH

SEARCH BY CITATION

References

  • Abou-Khalil B. (2005) Benefit-risk assessment of levetiracetam in the treatment of partial seizures. Drug Saf28:871890.
  • Ben-Menachem E, Falter U. (2000) Efficacy and tolerability of levetiracetam 3000 mg/d in patients with refractory partial seizures: a multicenter, double-blind, responder-selected study evaluating monotherapy. European Levetiracetam Study Group. Epilepsia41:12761283.
  • Berkovic S, Knowlton R, Leroy R, Schiemann J, Falter U. (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology69:17511760.
  • Brunner H, Nelen M, Breakefield X, Ropers H, van Oost B. (1993) Abnormal behavior associated with a point mutation in the structural gene for Monoamine Oxidase A. Science262:55785580.
  • Cases O, Seif I, Grimsby J, Gaspar P, Chen K, Pournin S, Müller U, Aguet M, Babinet C, Shih J, Maeyer E. (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science268:17631766.
  • Caspi A, Langley K, Milne B, Moffitt TE, O’Donovan M, Owen MJ, Polo Tomas M, Poulton R, Rutter M, Taylor A, Williams B, Thapar A. (2008) A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry65:203210.
  • Comings D, Comings B, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs B, Levy D, Smith M, Borison R, Evans D, Klein D, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S. (1991) The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA266:17931800.
  • Cordell H, Clayton D. (2005) Genetic association studies. Lancet366:12111311.
  • Craig I, Halton K. (2009) Genetics of human aggressive behaviour. Hum Genet126:101113.
  • Dinkelacker V, Dietl T, Widman G, Lengler U, Elger C. (2003) Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases. Epilepsy Behav4:537547.
  • Domschke K, Sheehan K, Lowe N, Kirley A, Mullins C, O’Sullivan R, Freitag C, Becker T, Conroy J, Fitzgerald M, Gill M, Hawi Z. (2005) Association analysis of the Monoamine Oxidase A and B genes with Attention Deficit Hyperactivity Disorder (ADHD) in an Irish sample: preferential transmission of the MAO-A 941G allele to affected children. Am J Med Genet B Neuropsychiatr Genet134B:110114.
  • Eisenberg J, Mei-Tal G, Steinberg A, Tartakovsky E, Zohar A, Gritsenko I, Nemanov L, Ebstein R. (1999) Haplotype relative risk study of Catechol-O-Methyltransferase (COMT) and Attention Deficit Hyperactivity Disorder (ADHD): association of the high-enzyme activity Val allele with ADHD impulsive-hyperactive phenotype. Am J Med Genet B Neuropsychiatr Genet88:497502.
  • French J, Pedley T. (2008) Initial management of epilepsy. N Engl J Med359:166176.
  • Giegling I, Hartmann A, Möller H, Rujescu D. (2006) Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J Affect Disord96:7581.
  • Gogos J, Morgan M, Luine V, Santha M, Ogawa S, Pfaff D, Karayiorgou M. (1998) Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc Natl Acad Sci USA95:99919996.
  • Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE. (2008) Positive and negative psychotropic effects of levetiracetam. Epilepsy Behav13:535541.
  • Hennig J, Reuter M, Netter P, Burk C, Landt O. (2005) Two types of aggression are differentially related to serotonergic activity and the A779C TPH polymorphism. Behav Neurosci119:1625.
  • Hess C, Reif A, Strobel A, Boreatti-Hümmer A, Heine M, Lesch K, Jacob C. (2009) A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm116:121130.
  • Kazantseva A, Gaysina D, Malykh S, Khusnutdinova E. (2011) The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits. Prog Neuropsychopharmacol Biol Psychiatry35:10331040.
  • Kestler L, Malhotra A, Finch C, Adler C, Breier A. (2000) The relation between dopamine D2 receptor density and personality: preliminary evidence from the NEO personality inventory-revised. Neuropsychiatry Neuropsychol Behav Neurol13:4852.
  • Kim C, Hahn M, Joung Y, Anderson S, Steele A, Mazei-Robinson M, Gizer I, Teicher M, Cohen B, Robertson D, Waldman I, Blakely R, Kim K. (2006) A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA103:1916419169.
  • Kirley A, Hawi Z, Daly G, McCarron M, Mullins C, Millar N, Waldman I, Fitzgerald M, Gill M. (2002) Dopaminergic system genes in ADHD: toward a biological hypothesis. Neuropsychopharmacology27:607619.
  • Lo BW, Kyu HH, Jichici D, Upton AM, Akl EA, Meade MO. (2011) Meta-analysis of randomized trials on first line and adjunctive levetiracetam. Can J Neurol Sci38:475486.
  • Lynch JM, Tate SK, Kinirons P, Weale ME, Cavalleri GL, Depondt C, Murphy K, O’Rourke D, Doherty CP, Shianna KV, Wood NW, Sander JW, Delanty N, Goldstein DB, Sisodiya SM. (2009) No major role of common SV2A variation for predisposition or levetiracetam response in epilepsy. Epilepsy Res83:4451.
  • Lyseng-Williamson KA. (2011) Levetiracetam: a review of its use in epilepsy. Drugs71:489514.
  • Manuck S, Flory J, Ferrell R, Dent K, Mann J, Muldoon M. (1999) Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry45:603614.
  • McCormack M, Alfirevic A, Bourgeois S, Farrell J, Kasperavičiūtė D, Carrington M, Sills G, Marson T, Jia X, de Bakker P, Chinthapalli K, Molokhia M, Johnson M, O’Connor G, Chaila E, Alhusaini S, Shianna K, Radtke R, Heinzen E, Walley N, Pandolfo M, Pichler W, Park B, Depondt C, Sisodiya S, Goldstein D, Deloukas P, Delanty N, Cavalleri G, Pirmohamed M. (2011) HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in europeans. N Engl J Med364:11341143.
  • Miller S, Dykes D, Polesky H. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res16:1215.
  • Munafo M, Matheson I, Flint J. (2007) Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol Psychiatry12:454461.
  • Munafo M, Timpson N, David S, Ebrahim S, Lawlor D. (2009) Association of the DRD2 gene Tag1A polymorphism and smoking behavior: a meta-analysis and new data. Nicotine Tob Res11:6476.
  • Nobile M, Rusconi M, Bellina M, Marino C, Giorda R, Carlet O, Vanzin L, Molteni M, Battaglia M. (2010) COMT Val158Met polymorphism and socioeconomic status interact to predict attention deficit/hyperactivity problems in children aged 10–14. Eur Child Adolesc Psychiatry19:549557.
  • Ritchie T, Noble E. (2003) Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res28:7382.
  • Rogeness G, Hernandez J, Macedo C, Mitchell EL. (1982) Biochemical differences in children with conduct disorder socialized and undersocialized. Am J Psychiatry139:307311.
  • Rosenthal R, Rubin D. (1982) A simple, general purpose display of magnitude of experimental effect. J Educ Psychol74:166169.
  • Skol A, Scott L, Abecasis G, Boehnke M. (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet38:209213.
  • Sole X, Guino E, Valls J, Iniesta R, Moreno V. (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics22:19281929.
  • Soyka M, Preuss U, Koller G, Zill P, Bondy B. (2004) Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm111:101109.
  • Stelzel C, Basten U, Montag C, Reuter M, Fiebach C. (2010) Frontostriatal involvement in task switching depends on genetic differences in d2 receptor density. J Neurosci30:1420514212.
  • Surges R, Volynski K, Walker M. (2008) Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisitedTher Adv Neurol Disord1:1324.
  • Terracciano A, Tanaka T, Sutin A, Sanna S, Deiana B, Lai S, Uda M, Schlessinger D, Abecasis G, Ferrucci L, Costa P. (2010) Genome-wide association scan of trait depression. Biol Psychiatry68:811817.
  • Xu X, Brookes K, Chen C, Huang Y, Wu Y, Asherson P. (2007) Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry7:10. doi:10.1186/1471-244X-7-10.
  • Zai C, Ehtesham S, Choi E, Nowrouzi B, de Luca V, Stankovich L, Davidge K, Freeman N, King N, Kennedy J, Beitchman J. (2011) Dopaminergic system genes in childhood aggression: possible role for DRD2. World J Biol Psychiatry3:6574.
  • Zhang H, Wang Y, Li J, Wang B, Yang L. (2005) Association between dopamine beta hydroxylase gene and attention deficit hyperactivity disorder complicated with disruptive behavior disorder. Zhonghua Er Ke Za Zhi43:2630.